Benzinga | Dec 15, 2021 06:41AM EST

Needham Maintains Buy on Generation Bio, Lowers Price Target to $27

Needham analyst Gil Blum maintains Generation Bio (NASDAQ:GBIO) with a Buy and lowers the price target from $50 to $27.